| Tag | Content |
|---|
EnhancerAtlas ID | HS101-32702 |
Organism | Homo sapiens |
Tissue/cell | HT29 |
Coordinate | chr4:75259920-75261740 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| PHOX2A | MA0713.1 | chr4:75261326-75261337 | TAATTGAATTA | - | 6.14 | | Phox2b | MA0681.1 | chr4:75261326-75261337 | TAATTGAATTA | - | 6.14 | | SOX10 | MA0442.2 | chr4:75261216-75261227 | AAAACAAAGAC | + | 6.14 | | Sox6 | MA0515.1 | chr4:75260286-75260296 | AAAACAATGG | - | 6.02 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_34466 | chr4:75259311-75261829 | HCT-116 | | SE_55838 | chr4:75256670-75261702 | u87 | | SE_56904 | chr4:75260263-75260569 | VACO_400 | | SE_67511 | chr4:75256670-75261702 | u87 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH04I074394 | chr4 | 75260239 | 75260900 |
|
Enhancer Sequence | AAAATAAATA AATAAATAAA TAAATAAAAG AAACTATCAG AGGGCTGGAG GTAGGGTGAT 60
GAAATAATTC AAAAAGATCA GTCTATCTGC TCTGCCGAAA GTAGACTAAA AAGGACAAGA 120
CTGAAAGATA AGGTGGGGAG TATTTTAATA ACCCACCTAA ATGGTTAGGG GAAAGATAGC 180
AGTAGTGGAA GTAATGAGAA AGTGTTGAAT TAGGAGTATA AGTAGACTAT ACTTAAATCA 240
ATAGGATTTG CTGATGGTTA TAACCAGGAC ATCTAGGAGA ACATAATGGC ATGAAACTCA 300
GAAGAAAGAA AAAAAAATCC AAGATTTACA GTGATAGTCA ACACGGTCTA ACAAAAAAAA 360
ATCTAGAAAA CAATGGGAAA GAAGAAAAAC GCCCCTGGTT TTGACCTCTG AATGTCATGA 420
AGCTTGAAAG AGAGTGCTTT TAGTGAGTGA TGAAAGTGGA GGCAGAATTG CACTAGATTA 480
AGGGAGTTGG TGGCGGCTGT TGGTAGAGAG TACTTATTTA GAATATTAGC CATGAAAGAA 540
AATGGAAGTG ACAAGCCCTC AATTGTTCAG TTGTTGATTA TATAGTTTTA GAATTAGCAG 600
GCCTTGTCCT TTTTTCTTGG GCCCTTTCTG TGTTCATTAC AATCTTTAGT AAAGGAGAGT 660
TGACATCAGG GAGGAGGTTA AGATTATCAG TTAAAACGGA AGTTGGGAAT ACCAGTGGTT 720
TTCGCTTCTT CCAGTCACCT CTGTCACTCC AACCACAGAT AGCTGAGAGT TGGCTCTCAC 780
CCTGAGTTTC AGGAAAGGGA CCAATGTGAG TGAGTCATGT GCTTACATTA GATGCAGTCT 840
TGATTAGAGT GGGAGAATCT GGCTGTGGGA ATATGAATAT GTCCCTTATC AGTGGGTAGG 900
GCCTTTTTAT ACATGGGTGG GGCTATGGAA CAGAAATCTG AATTGAAGAA CATACACATT 960
AGCTATATTG AAAATTCATT CTTCCGCAAT GCACACGATG TCTCCTGGAC CTGTCGATAA 1020
TGTTGTATAA TTTAGAAATC ATGAGTAGGA GGTTTTGGGC TAATGGATAC AAATCTTAGC 1080
TGACGTTTCA GGGGTAACAA TTTGTTATCC TTAATATGAG AATCTCCACT GTGGTATTCG 1140
TTAGGTTGGG GGCAATCTCC AGTAGTTAGT ATGTGTTTGT TTTCTGGTCC TTTGTTATTC 1200
TTTGGTAGTT AATAGAAGAA TTCAATGTTT ATTATTAATA CACTAATAGC AATTCGTCAT 1260
TCCTCCTTAG CACCAACCTA GGTTGTAAAA AGGCTTAAAA CAAAGACTGT AACAGAAAGA 1320
GTTTCTGAAT CTAGGCCCAC CCTGTAAAAT TTAGGTCATA AAATACATGT AAGGAATTAA 1380
CCTTGGAAAT TAAATTATAA AATAAGTAAT TGAATTATTT TGAAAGCTTT TACATAGAGA 1440
AAATGCAAAT TTAGCATATA AGAACTGCAC CTCTTCCACA GATTCTAATC AACCTTATTA 1500
CATTTTCTTT TGAGAATGTG CAGCACTTGG TTTCAGGCTT GGGATACTTT CCCAGGAAAC 1560
AAATCCACGA GGTCATGGCC CTTTAAAACA GTCATGCATC TGTTTACAAC TATGGAAAAG 1620
AGATTTCCTG GGTGTACGTT CCACCAAAGG ACAAGTTTAG GGGTCAGGCT TCAATGTCAT 1680
TCACCAACCT CAGTAGCAGG ATCTTGTGTC ACTGGAAGCC AGTTATAGCA TGTAATAAAG 1740
GTGTGGGTGT TTACATATGT GCACACATCT AATAAGAAGC TCACAGTTTC ATTTAAATTT 1800
ATGGCTACTT ATACCTCTTT 1820
|
